Health & Public Health covers major developments in healthcare, medicine, medical research, public health, food safety, health policy, insurance, drug safety, and safety issues affecting readers in the United States and around the world. This section focuses on clear, factual reporting from credible sources, including government health agencies, medical research institutions, public health organizations, and trusted news outlets. Coverage may include FDA updates, NIH research, disease prevention, healthcare costs, medication safety, public health alerts, hospital systems, and policy decisions that affect patients and communities.
The FDA has targeted eight retailers selling unauthorized tobacco products designed to mimic everyday items like candy and cough drops, raising concerns about child…
The State Department advises Americans to avoid travel to three African countries following an Ebola outbreak causing over 130 deaths
The ongoing Ebola outbreak has surpassed 500 cases with no vaccine or treatment available for the Bundibugyo virus responsible for the infections
Declining Affordable Care Act enrollment due to rising premiums and reduced subsidies is prompting insurers to raise rates again next year
Multiple Americans have been exposed to the Ebola virus in Congo amid a worsening outbreak declared a global health emergency
At least 80 people have died in Congo’s new Bundibugyo Ebola outbreak, prompting the WHO to declare a public health emergency amid rapid regional…
A recent Ebola outbreak in Africa has caused dozens of deaths as health officials work to contain the virus, while a U.S. doctor who…
As President Trump concludes his summit with China’s Xi Jinping, a dangerous Ebola outbreak in central Africa is intensifying international health concerns
Dr. Craig Spencer, an Ebola survivor, expresses concern for healthcare workers amid a new outbreak in Congo with limited treatments available
Dr. Tracy Beth Høeg departs as acting director of the FDA’s drug review center days after the commissioner’s resignation amid internal agency disputes
